American Well Corp AMWL
We take great care to ensure that the data presented and summarized in this overview for American Well Corp is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding AMWL
View all-
Black Rock Inc. New York, NY6.82MShares$53.5 Million0.0% of portfolio
-
Putnam Investments LLC Boston, MA212KShares$1.66 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V846KShares$360,8280.0% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ40.4KShares$317,0650.0% of portfolio
-
Rex Capital Advisors, LLC Providence, RI40.4KShares$317,0650.07% of portfolio
-
Aldebaran Financial Inc.21.3KShares$166,6860.01% of portfolio
-
Cannell & Co. New York, NY16.5KShares$129,3600.0% of portfolio
-
Corient Capital Partners, LLC Newport Beach, CA10.7KShares$83,7620.0% of portfolio
-
Perennial Advisors, LLC New York, NY10KShares$78,4000.0% of portfolio
-
Bartlett & Co. LLC210Shares$1,6460.0% of portfolio
Latest Institutional Activity in AMWL
Top Purchases
Top Sells
About AMWL
American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care. The company also provides telemedicine equipment, including telemedicine carts, peripherals, tyto care, TV kits, tablets, and kiosks. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
Insider Transactions at AMWL
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 05
2024
|
Mark Hirschhorn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
46,345
-17.78%
|
$370,760
$8.97 P/Share
|
Nov 04
2024
|
Mark Hirschhorn Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
257,477
+49.69%
|
-
|
Nov 01
2024
|
Paul Francis Mc Neice Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
9
-0.1%
|
$72
$8.93 P/Share
|
Nov 01
2024
|
Phyllis Gotlib President, International |
SELL
Open market or private sale
|
Direct |
224
-0.2%
|
$1,792
$8.93 P/Share
|
Nov 01
2024
|
Kurt Knight Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
268
-0.18%
|
$2,144
$8.93 P/Share
|
Oct 01
2024
|
Kurt Knight Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
682
-0.47%
|
$6,138
$9.15 P/Share
|
Oct 01
2024
|
Vukasin Paunovich EVP, Enterprise Platforms |
SELL
Open market or private sale
|
Direct |
398
-0.33%
|
$3,582
$9.15 P/Share
|
Oct 01
2024
|
Robert Shepardson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
876
-0.78%
|
$7,884
$9.15 P/Share
|
Oct 01
2024
|
Phyllis Gotlib President, International |
SELL
Open market or private sale
|
Direct |
798
-0.7%
|
$7,182
$9.15 P/Share
|
Oct 01
2024
|
Paul Francis Mc Neice Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
84
-0.88%
|
$756
$9.15 P/Share
|
Sep 03
2024
|
Kurt Knight Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,053
-2.04%
|
$21,371
$7.87 P/Share
|
Sep 03
2024
|
Phyllis Gotlib President, International |
SELL
Open market or private sale
|
Direct |
3,574
-3.02%
|
$25,018
$7.87 P/Share
|
Sep 03
2024
|
Paul Francis Mc Neice Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
165
-1.71%
|
$1,155
$7.87 P/Share
|
Sep 03
2024
|
Kathy Johnson Weiler Chief Comm. & Growth Officer |
SELL
Open market or private sale
|
Direct |
7,266
-3.72%
|
$50,862
$7.87 P/Share
|
Sep 03
2024
|
Vukasin Paunovich EVP, Enterprise Platforms |
SELL
Open market or private sale
|
Direct |
3,141
-2.55%
|
$21,987
$7.87 P/Share
|
Sep 03
2024
|
Robert Shepardson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,177
-4.38%
|
$36,239
$7.87 P/Share
|
Aug 01
2024
|
Paul Francis Mc Neice Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
8
-0.08%
|
$72
$9.56 P/Share
|
Aug 01
2024
|
Kurt Knight Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
268
-0.18%
|
$2,412
$9.56 P/Share
|
Aug 01
2024
|
Phyllis Gotlib President, International |
SELL
Open market or private sale
|
Direct |
225
-0.19%
|
$2,025
$9.56 P/Share
|
Jul 01
2024
|
Paul Francis Mc Neice Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,670
-0.86%
|
$0
$0.3 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 15.8M shares |
---|
Open market or private sale | 2.33M shares |
---|